Allergy Therapeutics revenues rise 10.6 as cash reserves grow

Allergy Therapeutics revenues rise 10.6% as cash reserves grow

02:41 EST 16 Jan 2019 | Proactive Investors

The drug developer's trading statement revealed the latest numbers were in line with market forecasts

Original Article: Allergy Therapeutics revenues rise 10.6% as cash reserves grow

More From BioPortfolio on "Allergy Therapeutics revenues rise 10.6% as cash reserves grow"